Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MEDIF

MediPharm Labs Corp.

USD

Set alert

Price alert · MEDIF

All alert types
0.05 USD 0.00 0.00%
As of Oct 30, 2026
0.0462 Day range 0.0462
0.042 52-week range 0.067
YTD
-3.92%
1 year
-9.26%
Open
0.0462
Prev close
0.049
Mkt cap
20.93M
Vol
2.04K
Avg vol
53.58K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0462
High
0.0462

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MEDIF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.53 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -3.5×
FY 2017: 0.0×FY 2018: -14.2×FY 2019: 410×FY 2020: -1.1×FY 2021: -0.8×FY 2022: -0.6×FY 2023: -1.8×FY 2024: -2.3×FY 2025: -3.5×
FY 2017 5y median -1.8× FY 2025
P/S 0.6×
FY 2017: 0.0×FY 2018: 11.7×FY 2019: 3.6×FY 2020: 2.0×FY 2021: 2.1×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.6×
FY 2017 5y median 0.7× FY 2025
P/B 0.8×
FY 2017: 28.3×FY 2018: 4.3×FY 2019: 3.5×FY 2020: 0.9×FY 2021: 0.6×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.6×FY 2025: 0.8×
FY 2017 5y median 0.6× FY 2025
P/FCF -5.4×
FY 2017: 0.0×FY 2018: -4.6×FY 2019: -8.0×FY 2020: -1.6×FY 2021: -3.3×FY 2022: -1.1×FY 2023: -1.9×FY 2024: -4.8×FY 2025: -5.4×
FY 2017 5y median -3.3× FY 2025
EV/EBITDA -2.7×
FY 2017: -11.6×FY 2018: -16.8×FY 2019: 44.7×FY 2020: -1.3×FY 2021: -0.3×FY 2022: 0.2×FY 2023: -0.7×FY 2024: -1.7×FY 2025: -2.7×
FY 2017 5y median -0.7× FY 2025
EV/Sales 0.4×
FY 2017: 0.0×FY 2018: 11.5×FY 2019: 3.4×FY 2020: 2.0×FY 2021: 0.6×FY 2022: -0.2×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.4×
FY 2017 5y median 0.3× FY 2025
FCF Yield -18.5%
FY 2017: 0.0%FY 2018: -21.5%FY 2019: -12.5%FY 2020: -62.7%FY 2021: -30.3%FY 2022: -92.7%FY 2023: -52.3%FY 2024: -20.7%FY 2025: -18.5%
FY 2017 5y median -30.3% FY 2025

Profitability

Gross Margin 29.1%
FY 2017: 0.0%FY 2018: 38.9%FY 2019: 33.2%FY 2020: -122.1%FY 2021: -70.2%FY 2022: -8.7%FY 2023: 17.7%FY 2024: 30.5%FY 2025: 29.1%
FY 2017 5y median 17.7% FY 2025
Operating Margin -19.2%
FY 2017: 0.0%FY 2018: -79.0%FY 2019: 5.4%FY 2020: -201.5%FY 2021: -225.3%FY 2022: -133.5%FY 2023: -55.2%FY 2024: -25.8%FY 2025: -19.2%
FY 2017 5y median -55.2% FY 2025
Net Margin -18.3%
FY 2017: 0.0%FY 2018: -82.2%FY 2019: 0.9%FY 2020: -186.4%FY 2021: -252.4%FY 2022: -135.6%FY 2023: -39.6%FY 2024: -25.5%FY 2025: -18.3%
FY 2017 5y median -39.6% FY 2025
ROE -23.1%
FY 2017: 0.0%FY 2018: -30.3%FY 2019: 0.9%FY 2020: -85.6%FY 2021: -65.9%FY 2022: -53.5%FY 2023: -24.7%FY 2024: -24.8%FY 2025: -23.1%
FY 2017 5y median -24.8% FY 2025
ROIC -24.0%
FY 2017: 0.0%FY 2018: -23.8%FY 2019: 0.8%FY 2020: -66.4%FY 2021: -58.5%FY 2022: -52.1%FY 2023: -32.3%FY 2024: -24.8%FY 2025: -24.0%
FY 2017 5y median -32.3% FY 2025
ROA -18.1%
FY 2017: 0.0%FY 2018: -19.6%FY 2019: 0.7%FY 2020: -56.8%FY 2021: -59.3%FY 2022: -45.8%FY 2023: -20.5%FY 2024: -19.9%FY 2025: -18.1%
FY 2017 5y median -20.5% FY 2025

Growth (YoY)

Revenue 7.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 1167.4%FY 2020: -72.1%FY 2021: -39.7%FY 2022: 1.9%FY 2023: 49.5%FY 2024: 26.9%FY 2025: 7.5%
FY 2017 FY 2025
Operating Income 20.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 186.2%FY 2020: -1146.1%FY 2021: 32.6%FY 2022: 39.6%FY 2023: 38.2%FY 2024: 40.8%FY 2025: 20.1%
FY 2017 FY 2025
EPS (diluted) 24.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 107.0%FY 2020: -5814.3%FY 2021: 54.2%FY 2022: 50.0%FY 2023: 67.3%FY 2024: 27.2%FY 2025: 24.4%
FY 2017 FY 2025
Free Cash Flow -8.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -124.7%FY 2020: 21.5%FY 2021: 69.1%FY 2022: -21.0%FY 2023: 27.7%FY 2024: 59.0%FY 2025: -8.2%
FY 2017 FY 2025

Financial Health

Current Ratio 2.8×
FY 2017: 63.5×FY 2018: 1.8×FY 2019: 4.1×FY 2020: 3.4×FY 2021: 7.4×FY 2022: 5.0×FY 2023: 3.4×FY 2024: 3.2×FY 2025: 2.8×
FY 2017 5y median 3.4× FY 2025
Quick Ratio 2.0×
FY 2017: 63.5×FY 2018: 1.2×FY 2019: 2.4×FY 2020: 2.4×FY 2021: 6.1×FY 2022: 4.2×FY 2023: 2.5×FY 2024: 2.3×FY 2025: 2.0×
FY 2017 5y median 2.5× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 1.5×
FY 2017: 0.4×FY 2018: 0.3×FY 2019: -2.9×FY 2020: 0.0×FY 2021: 0.9×FY 2022: 0.9×FY 2023: 1.5×FY 2024: 1.5×FY 2025: 1.5×
FY 2017 5y median 1.5× FY 2025
Interest Coverage -137×
FY 2017: 0.0×FY 2018: -22.7×FY 2019: 10.3×FY 2020: -9.2×FY 2021: -4.7×FY 2022: -953×FY 2023: -50.0×FY 2024: -18.8×FY 2025: -137×
FY 2017 5y median -50.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31